Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK

被引:34
|
作者
Gadroen, Kartini [1 ]
Dodd, Caitlin N. [1 ]
Masclee, Gwen M. C. [1 ]
de Ridder, Maria A. J. [1 ]
Weibel, Daniel [1 ]
Mina, Michael J. [2 ]
Grenfell, Bryan T. [3 ]
Sturkenboom, Miriam C. J. M. [1 ]
van de Vijver, David A. M. C. [4 ]
de Swart, Rik L. [4 ]
机构
[1] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands
[2] Harvard Med Sch, Dept Pathol, Boston, MA USA
[3] Princeton Univ, Dept Ecol & Evolutionary Biol, Guyot, NJ USA
[4] Erasmus MC, Dept Virosci, Rotterdam, Netherlands
来源
BMJ OPEN | 2018年 / 8卷 / 11期
关键词
measles; immune suppression; LYMPHOCYTES; REDUCTION; MORTALITY;
D O I
10.1136/bmjopen-2017-021465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To test the hypothesis that measles infection increases the incidence of non-measles infectious diseases over a prolonged period of time. Design A population-based matched cohort study. Data sources This study examined children aged 1-15 years in The Health Improvement Network UK general practice medical records database. Participants included 2228 patients diagnosed with measles between 1990 and 2014, which were matched on age, sex, general practitioner practice and calendar year with 19930 children without measles. All controls had received at least one measles vaccination. Children with a history of immune-compromising conditions or with immune-suppressive treatment were excluded. Primary outcome measures Incidence rate ratio (IRR) of infections, anti-infective prescriptions and all-cause hospitalisations following measles in predetermined periods using multivariate analysis to adjust for confounding variables. Results In children with measles, the incidence rate for non-measles infectious disease was significantly increased in each time period assessed up to 5 years postmeasles: 43% in the first month (IRR: 1.43; 95%CI 1.22 to 1.68), 22% from month one to the first year (IRR: 1.22; 95%CI 1.14 to 1.31), 10% from year 1 to 2.5 years (IRR: 1.10; 95%CI 1.02 to 1.19) and 15% (IRR: 1.15; 95%CI 1.06 to 1.25) in years 2.5 to 5 years of follow-up. Children with measles were more than three times as likely to receive an anti-infective prescription in the first month and 15%-24%more likely between the first month and 5 years. The rate of hospitalisation in children with measles was increased only in the month following diagnosis but not thereafter (IRR: 2.83; 95%CI 1.72 to 4.67). Conclusion Following measles, children had increased rates of diagnosed infections, requiring increased prescribing of antimicrobial therapies. This population-based matched cohort study supports the hypothesis that measles has a prolonged impact on host resistance to non-measles infectious diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic Drugs A Retrospective Cohort Study using the UK General Practice Research Database
    Ackers, Ruth
    Besag, Frank M. C.
    Hughes, Elaine
    Squier, Waney
    Murray, Macey L.
    Wong, Ian C. K.
    DRUG SAFETY, 2011, 34 (05) : 403 - 413
  • [32] Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic DrugsA Retrospective Cohort Study using the UK General Practice Research Database
    Ruth Ackers
    Frank M.C. Besag
    Elaine Hughes
    Waney Squier
    Macey L. Murray
    Ian C.K. Wong
    Drug Safety, 2011, 34 : 403 - 413
  • [33] Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink
    Kendal Chidwick
    Helen Strongman
    Anthony Matthews
    Susannah Stanway
    Alexander R. Lyon
    Liam Smeeth
    Krishnan Bhaskaran
    BMC Cancer, 18
  • [34] Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink
    Chidwick, Kendal
    Strongman, Helen
    Matthews, Anthony
    Stanway, Susannah
    Lyon, Alexander R.
    Smeeth, Liam
    Bhaskaran, Krishnan
    BMC CANCER, 2018, 18
  • [35] Higher rates of non-skeletal complications and greater healthcare needs in achondroplasia compared to the general UK population: a matched cohort study using the CPRD database
    Jeanne M. Pimenta
    Melita Irving
    Moira Cheung
    Louise Mazzeo
    Sarah Landis
    Swati Mukherjee
    Orphanet Journal of Rare Diseases, 18
  • [36] Higher rates of non-skeletal complications and greater healthcare needs in achondroplasia compared to the general UK population: a matched cohort study using the CPRD database
    Pimenta, Jeanne M.
    Irving, Melita
    Cheung, Moira
    Mazzeo, Louise
    Landis, Sarah
    Mukherjee, Swati
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [37] No Evidence of a Strong Association between Orlistat and Pancreatitis. Results from a Study Using the UK General Practice Research Database (GPRD)
    Schuerch, Markus
    Robinson, Noah J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S170 - S170
  • [38] Re: The Risk of Adverse Outcomes in Association with Use of Testosterone Products: A Cohort Study Using the UK-Based General Practice Research Database Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1827 - 1827
  • [39] Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink
    Jain, Anu
    Walker, Jemma L.
    Mathur, Rohini
    Forbes, Harriet J.
    Langan, Sinead M.
    Smeeth, Liam
    van Hoek, Albert J.
    Thomas, Sara L.
    PLOS ONE, 2018, 13 (11):
  • [40] COMPARATIVE RISK OF VENOUS THROMBOEMBOLISM AMONGST USERS OF DIFFERENT ANTI-OSTEOPOROSIS DRUGS IN THE UK: A PROPENSITY-MATCHED COHORT STUDY USING DATA FROM THE CLINICAL PRACTICE RESEARCH DATALINK
    Khalid, Sara
    Prieto-Alhambra, Daniel
    Hawley, Samuel
    Ali, Mohammed Sanni
    Judge, Andrew
    Arden, Nigel
    Van Staa, Tjeerd P.
    Cooper, Cyrus
    Javaid, Kassim
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : 673 - 674